Literature DB >> 8887445

Triethyltin interferes with Ca2+ signaling and potentiates norepinephrine release in PC12 cells.

B Viviani1, A D Rossi, S C Chow, P Nicotera.   

Abstract

We have investigated the effects of triethyltin (TET) on agonist-stimulated Ca2+ signaling and neurosecretion in PC12 cells. Treatment of PC12 cells with 10 microM TET elicited a slow increase of the resting cytosolic free Ca2+ concentration due to Ca2+ release from intracellular stores. Furthermore, TET modified the Ca2+ responses elicited by bradykinin (Bk), adenosine triphosphate (ATP), or high K+. TET potentiated the peak Ca2+ response stimulated by Bk in both the presence and the absence of extracellular Ca2+, and prolonged the recovery phase after ATP stimulation. In contrast, the Ca2+ transient elicited by bathing cells in high K+ was markedly reduced, suggesting that TET can differentially affect several targets on Ca2+-signaling pathways. Neurotransmitter depletion follows in vivo exposure to TET. Since neurotransmitter secretion is strictly dependent on intracellular Ca2+ signals we also investigated whether treatment with TET modified norepinephrine release from PC12 cells. TET did not elicit norepinephrine release, but it enhanced the release of norepinephrine induced by Bk or ATP. The increased release of norepinephrine elicited in combination with Bk was independent from extracellular Ca2+. Our results suggest that possible neurotoxic effects of TET can derive from its ability to modulate Ca2+ signaling and eventually neurosecretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887445     DOI: 10.1006/taap.1996.0224

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  2 in total

1.  In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo.

Authors:  Angela Alama; Maurizio Viale; Michele Cilli; Cristina Bruzzo; Federica Novelli; Bruno Tasso; Fabio Sparatore
Journal:  Invest New Drugs       Date:  2008-06-19       Impact factor: 3.850

2.  Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin(IV)lupinylsulfide hydrochloride.

Authors:  Federica Barbieri; Fabio Sparatore; Rudy Bonavia; Cristina Bruzzo; Gennaro Schettini; Angela Alama
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.